Forest Vows To Double Pipeline Potential
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm restates commitment to aclidinium for COPD.
You may also be interested in...
Optimer Looks To Partner C. Diff Candidate After Trial Success
OPT-80’s success in the clinic dramatically improves Optimer’s ability to partner the product for a healthy sum.
Optimer Looks To Partner C. Diff Candidate After Trial Success
OPT-80’s success in the clinic dramatically improves Optimer’s ability to partner the product for a healthy sum.
Scrapping Its IPO, Phenomix Teams Up With Forest
The deal funds ongoing clinical development of dutogliptin and provides a cushion in difficult financial times.